Particularitatile formarii preturilor la produsele farmaceutice în Republica Moldova
Închide
Articolul precedent
Articolul urmator
806 45
Ultima descărcare din IBN:
2024-05-15 09:48
Căutarea după subiecte
similare conform CZU
338.5:615(478) (1)
Preț. Formarea prețului. Costuri (108)
Farmacologie. Terapeutică. Toxicologie (1612)
SM ISO690:2012
TAGARCEA, Mihaela. Particularitatile formarii preturilor la produsele farmaceutice în Republica Moldova. In: Sesiune națională cu participare internațională de comunicări științifice studențești, Ed. 24, 15 februarie 2020, Chișinău. Chișinău, Republica Moldova: Centrul Editorial-Poligrafic al USM, 2020, Ediția 24, Vol.1, pp. 129-131. ISBN 978-9975-142-89-2.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Sesiune națională cu participare internațională de comunicări științifice studențești
Ediția 24, Vol.1, 2020
Sesiunea "Sesiune naţională de comunicări ştiinţifice studenţeşti"
24, Chișinău, Moldova, 15 februarie 2020

Particularitatile formarii preturilor la produsele farmaceutice în Republica Moldova

CZU: 338.5:615(478)

Pag. 129-131

Tagarcea Mihaela
 
Universitatea de Stat din Moldova
 
 
Disponibil în IBN: 7 mai 2020


Rezumat

Piaţa produselor farmaceutice prezintă anumite elemente specifice, în comparaţie cu pieţele pentru alte bunuri şi servicii, care limitează aplicarea deplină a mecanismelor economiei de piaţă bazate pe inte­rac­ţiu­nea liberă dintre cerere şi ofertă. De aceea apare necesitatea existenţei unor reglementări specifice pieţei farmaceutice în scopul asigurării inofensivităţii şi calităţii produselor comercializate. Regle­men­tarea excesivă şi lipsa mecanismelor pe deplin funcţionale creează distorsiuni pe piaţa farmaceutică, care duc la monopolizarea acestui sector pe segmentul importului de produse farmaceutice şi generează un mediu concurenţial slab pe segmentul de comercializare cu amă­nun­tul. Astfel, consumatorii sunt puşi în situaţia să achite preţuri ne­jus­ti­fi­cat de mari pentru medicamentele procurate în ţară. Preţurile mari creează, la rândul lor, premise pentru apariţia produselor farmaceutice contrafăcute. Cadrul instituţional imperfect aplicat în prezent este prin­cipala cauză a preţurilor exagerate la produsele farmaceutice. Metodologia studiului a inclus analiza bazei legislative şi normative de reglementare a pieţei farmaceutice, analiza datelor statistice privind producţia şi comercializarea produselor farmaceutice.Sectorul farmaceutic reprezintă un domeniu prioritar, supus unei reglementări stricte, a cărui mecanisme complexe au făcut obiectul unei analize constante şi atente la nivel guvernamental. Garantarea aplicării unui nivel rezonabil al preţurilor pe această piaţă, ţinând cont de nivelul redus al veniturilor reale ale populaţiei ţării, este asigurată mai mult prin aplicarea unor măsuri administrative decât prin buna funcţionare a mecanismelor economiei de piaţă.Cererea pe piaţa farmaceutică este formată din:1. Medicamente cu prescripţie. Acest mod specific de formare a cererii pentru medicamentele cu prescripţie duce la o alterare sem­nificativă a modului de funcţionare a mecanismelor economiei de piaţă.2. Medicamente fără prescripţie. Această categorie e caracterizează prin substituibilitatea medicamentelor şi/sau a terapiilor în practica medicală de zi cu zi (medicamente alternative).3. Medicamente procurate de stat. În această categorie putem enumera două forme de intervenţie a statului pe piaţă: achiziţionarea medicamentelor prin licitaţii publice pentru necesităţile instituţiilor publice și compensarea medicamentelor de către stat, parţial sau total, din contul mijloacelor bugetare.Fig. Elementele componente ale prețului la produsele farmaceuticePiaţa medicamentelor a cunoscut o dezvoltare dinamică continuă pe durata a mai multor ani. Această realitate a permis producătorilor interni, deşi puţini la număr, să-şi extindă capacităţile de producţie. În acelaşi timp, marii producători străini de produse farmaceutice pătrund tot mai mult pe piaţa Republicii Moldova. Distribuitorii şi-au consolidat poziţia pe piaţă pe măsură ce fluxurile comerciale au crescut, în timp ce co­mer­cianţii cu amănuntul au cunoscut o expansiune rapidă a reţelei de vânzare.Comerţul cu ridicata este realizat de depozitele farmaceutice şi im­por­tatorii de produse farmaceutice. Întreprinderile care importă şi/sau distribuie cu ridicata medicamente, atât de import, cât şi autohtone, pot aplica un adaos comercial de maxim 15%. Comerţul cu amănuntul este efectuat prin farmacii. Preţul medicamentelor în farmacii se stabileşte cu un adaos comercial de maxim 25%.Prețul produselor farmaceutice este format dintr-un șir de elemente care influențează mărimea acestuia (Fig.).Cererea pentru produsele farmaceutice prezintă o elasticitate redu­să în raport cu preţul de comercializare, în comparaţie cu alte produse şi servicii aflate pe piaţă. Acest fapt face ca influenţa majorării pre­ţu­ri­lor de comercializare a produselor farmaceutice asupra bunăstării po­pu­­laţiei să fie una mare, în special pentru păturile vulnerabile ale so­cie­tăţii.

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Tagarcea, M.</creatorName>
<affiliation>Universitatea de Stat din Moldova, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='ro'>Particularitatile formarii preturilor la produsele farmaceutice &icirc;n Republica Moldova</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2020</publicationYear>
<relatedIdentifier relatedIdentifierType='ISBN' relationType='IsPartOf'>978-9975-142-89-2</relatedIdentifier>
<subjects>
<subject schemeURI='http://udcdata.info/' subjectScheme='UDC'>338.5:615(478)</subject>
</subjects>
<dates>
<date dateType='Issued'>2020</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Conference Paper</resourceType>
<descriptions>
<description xml:lang='ro' descriptionType='Abstract'><p>Piaţa produselor farmaceutice prezintă anumite elemente specifice, &icirc;n comparaţie cu pieţele pentru alte bunuri şi servicii, care limitează aplicarea deplină a mecanismelor economiei de piaţă bazate pe inte&shy;rac&shy;ţiu&shy;nea liberă dintre cerere şi ofertă. De aceea apare necesitatea existenţei unor reglementări specifice pieţei farmaceutice &icirc;n scopul asigurării inofensivităţii şi calităţii produselor comercializate. Regle&shy;men&shy;tarea excesivă şi lipsa mecanismelor pe deplin funcţionale creează distorsiuni pe piaţa farmaceutică, care duc la monopolizarea acestui sector pe segmentul importului de produse farmaceutice şi generează un mediu concurenţial slab pe segmentul de comercializare cu amă&shy;nun&shy;tul. Astfel, consumatorii sunt puşi &icirc;n situaţia să achite preţuri ne&shy;jus&shy;ti&shy;fi&shy;cat de mari pentru medicamentele procurate &icirc;n ţară. Preţurile mari creează, la r&acirc;ndul lor, premise pentru apariţia produselor farmaceutice contrafăcute. Cadrul instituţional imperfect aplicat &icirc;n prezent este prin&shy;cipala cauză a preţurilor exagerate la produsele farmaceutice. Metodologia studiului a inclus analiza bazei legislative şi normative de reglementare a pieţei farmaceutice, analiza datelor statistice privind producţia şi comercializarea produselor farmaceutice.</p><p>Sectorul farmaceutic reprezintă un domeniu prioritar, supus unei reglementări stricte, a cărui mecanisme complexe au făcut obiectul unei analize constante şi atente la nivel guvernamental. Garantarea aplicării unui nivel rezonabil al preţurilor pe această piaţă, ţin&acirc;nd cont de nivelul redus al veniturilor reale ale populaţiei ţării, este asigurată mai mult prin aplicarea unor măsuri administrative dec&acirc;t prin buna funcţionare a mecanismelor economiei de piaţă.</p><p>Cererea pe piaţa farmaceutică este formată din:</p><p>1. Medicamente cu prescripţie. Acest mod specific de formare a cererii pentru medicamentele cu prescripţie duce la o alterare sem&shy;nificativă a modului de funcţionare a mecanismelor economiei de piaţă.</p><p>2. Medicamente fără prescripţie. Această categorie e caracterizează prin substituibilitatea medicamentelor şi/sau a terapiilor &icirc;n practica medicală de zi cu zi (medicamente alternative).</p><p>3. Medicamente procurate de stat. &Icirc;n această categorie putem enumera două forme de intervenţie a statului pe piaţă: achiziţionarea medicamentelor prin licitaţii publice pentru necesităţile instituţiilor publice și compensarea medicamentelor de către stat, parţial sau total, din contul mijloacelor bugetare.</p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
  path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="Схема_x0020_3" o:spid="_x0000_s1026" type="#_x0000_t75"
  style='position:absolute;left:0;text-align:left;margin-left:7.95pt;
  margin-top:5.7pt;width:300.95pt;height:223.2pt;z-index:251657728;
  visibility:visible;mso-wrap-distance-left:9.96pt;mso-wrap-distance-bottom:6.21pt;
  mso-position-horizontal-relative:margin' o:gfxdata="UEsDBBQABgAIAAAAIQDq7GcDXgEAAHYEAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbLRUXU/CMBR9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">
  <v:imagedata src="file:///C:/Users/PHOBOS/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
  <o:lock v:ext="edit" aspectratio="f"/>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--></p><p><!--[if gte vml 1]></o:wrapblock><![endif]-->Fig. Elementele componente ale prețului la produsele farmaceutice</p><p>Piaţa medicamentelor a cunoscut o dezvoltare dinamică continuă pe durata a mai multor ani. Această realitate a permis producătorilor interni, deşi puţini la număr, să-şi extindă capacităţile de producţie. &Icirc;n acelaşi timp, marii producători străini de produse farmaceutice pătrund tot mai mult pe piaţa Republicii Moldova. Distribuitorii şi-au consolidat poziţia pe piaţă pe măsură ce fluxurile comerciale au crescut, &icirc;n timp ce co&shy;mer&shy;cianţii cu amănuntul au cunoscut o expansiune rapidă a reţelei de v&acirc;nzare.</p><p>Comerţul cu ridicata este realizat de depozitele farmaceutice şi im&shy;por&shy;tatorii de produse farmaceutice. &Icirc;ntreprinderile care importă şi/sau distribuie cu ridicata medicamente, at&acirc;t de import, c&acirc;t şi autohtone, pot aplica un adaos comercial de maxim 15%. Comerţul cu amănuntul este efectuat prin farmacii. Preţul medicamentelor &icirc;n farmacii se stabileşte cu un adaos comercial de maxim 25%.</p><p>Prețul produselor farmaceutice este format dintr-un șir de elemente care influențează mărimea acestuia (Fig.).</p><p>Cererea pentru produsele farmaceutice prezintă o elasticitate redu&shy;să &icirc;n raport cu preţul de comercializare, &icirc;n comparaţie cu alte produse şi servicii aflate pe piaţă. Acest fapt face ca influenţa majorării pre&shy;ţu&shy;ri&shy;lor de comercializare a produselor farmaceutice asupra bunăstării po&shy;pu&shy;&shy;laţiei să fie una mare, &icirc;n special pentru păturile vulnerabile ale so&shy;cie&shy;tăţii.</p></description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>